Elisabeth Stogmann

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications

Response to Amalia.

Response to Amalia.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: December 04, 2025

A multimodal lifestyle intervention management system for people at risk of cognitive decline.

A multimodal lifestyle intervention management system for people at risk of cognitive decline.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Published: December 03, 2025

Attitudes of specialist memory-clinic patients with early symptomatic Alzheimer's disease towards lecanemab: results from a multicenter survey in Europe.

Attitudes of specialist memory-clinic patients with early symptomatic Alzheimer's disease towards lecanemab: results from a multicenter survey in Europe.

Journal: Scientific reports
Published: November 15, 2025

Peripheral CHI3L1 expression is associated with APOE ε4 status in early-onset Alzheimer's disease.

Peripheral CHI3L1 expression is associated with APOE ε4 status in early-onset Alzheimer's disease.

Journal: Frontiers in aging neuroscience
Published: October 22, 2025

Resources of Austrian hospital-based departments of neurology and psychiatry for new amyloid-antibody therapies in early Alzheimer dementia : A survey of the Austrian Alzheimer Society.

Resources of Austrian hospital-based departments of neurology and psychiatry for new amyloid-antibody therapies in early Alzheimer dementia : A survey of the Austrian Alzheimer Society.

Journal: Wiener klinische Wochenschrift
Published: June 12, 2025

Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease.

Comment by European Alzheimer's Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer' s disease.

Journal: The journal of prevention of Alzheimer's disease
Published: May 20, 2025

Dynamic relationship between cerebrospinal fluid immune cells and tissue damage markers in multiple sclerosis.

Dynamic relationship between cerebrospinal fluid immune cells and tissue damage markers in multiple sclerosis.

Journal: Brain communications
Published: May 07, 2025

Ultrasound Neuromodulation With Transcranial Pulse Stimulation in Alzheimer Disease: A Randomized Clinical Trial.

Ultrasound Neuromodulation With Transcranial Pulse Stimulation in Alzheimer Disease: A Randomized Clinical Trial.

Journal: JAMA network open
Published: February 26, 2025

Assessing family history and approaches for identifying patients with dementia with diagnostically significant genetic findings.

Assessing family history and approaches for identifying patients with dementia with diagnostically significant genetic findings.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: January 29, 2025

Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease.

Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease.

Journal: JAMA neurology
Published: January 09, 2025

Antiplatelet therapy is not associated with increased risk of complications after lumbar puncture.

Antiplatelet therapy is not associated with increased risk of complications after lumbar puncture.

Journal: Journal of neurology
Published: November 14, 2024

Effect of Initiation With Sacubitril/valsartan on Blood Neurodegeneration Markers in HFrEF.

Effect of Initiation With Sacubitril/valsartan on Blood Neurodegeneration Markers in HFrEF.

Journal: Journal of cardiac failure
Published: October 20, 2024
Showing 1-12 of 67

Last Updated: 09/26/2026